Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0LC2B
|
||||
Former ID |
DIB016194
|
||||
Drug Name |
NSP-805
|
||||
Synonyms |
TZN-01; 5-Methyl-6-[4-(2-methyl-3-oxo-1-cyclopentenylamino)phenyl]-2,3,4,5-tetrahydropyridazin-3-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Heart failure [ICD9: 428; ICD10:I50] | Discontinued in Phase 2 | [545097] | ||
Structure |
Download2D MOL |
||||
Formula |
C17H19N3O2
|
||||
Canonical SMILES |
CC1CC(=O)NN=C1C2=CC=C(C=C2)NC3=C(C(=O)CC3)C
|
||||
InChI |
1S/C17H19N3O2/c1-10-9-16(22)19-20-17(10)12-3-5-13(6-4-12)18-14-7-8-15(21)11(14)2/h3-6,10,18H,7-9H2,1-2H3,(H,19,22)
|
||||
InChIKey |
DSRIICXPBQXOKK-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 125068-54-4
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Phosphodiesterase (PDE) 3 | Target Info | Modulator | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.